| First Author | Apostolova MD | Year | 1997 |
| Journal | J Trace Elem Med Biol | Volume | 11 |
| Issue | 1 | Pages | 1-7 |
| PubMed ID | 9176863 | Mgi Jnum | J:41905 |
| Mgi Id | MGI:894619 | Doi | 10.1016/S0946-672X(97)80001-6 |
| Citation | Apostolova MD, et al. (1997) Analysis of the possible protective role of metallothionein in streptozotocin-induced diabetes using metallothionein-null mice. J Trace Elem Med Biol 11(1):1-7 |
| abstractText | In order to clarify a possible protective role of metallothionein (MT) in the development of streptozotocin (STZ)-caused insulin-dependent diabetes mellitus (IDDM) and its mechanisms, we studied whether MT is effective for protection against STZ-caused IDDM by utilizing MT-null (isoforms MT-I and II) transgenic mice. It was found that Zn pretreatment (I mg/kg body weight as ZnSO4) has a unique inhibitory effect on IDDM development in MT-null mice in contrast to no marked effect in control (C57BL/6J) mice, suggesting that Zn ions free from MT molecules exerted this protective effect. The highest Zn dose (10 mg/kg body weight) fully suppressed development of hyperglycaemia in both types of mice. Pretreatment with Zn partially led to recovery of superoxide dismutase activities in the liver and pancreas in which STZ administration suppressed superoxide dismutase activity in both types of mice. The present study suggests that Zn plays an important role in the pathogenesis of IDDM, although a possible involvement of MT in the protection of STZ-caused IDDM cannot be completely negated. |
